CBD Scrutiny May Signal Broader FDA Enforcement Trend
On April 2, 2019, the U.S. Food and Drug Administration issued a statement by FDA Commissioner Scott Gottlieb announcing the agency's latest enforcement actions taken against companies allegedly engaging in unlawful...To view the full article, register now.
Already a subscriber? Click here to view full article